Cormorant Asset Management
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
United States, Boston
The primary office of this VC is located in Boston. The fund is located in United States, North America.
The fund usually invests in rounds together with 6-7 others. Aside from Cormorant Asset Management, start-ups are often funded by ARCH Venture Partners, Third Rock Ventures, New Enterprise Associates and 74 other funds. Other VCs who often invest in the same rounds are Foresite Capital, Wellington Management, EcoR1 Capital, the total number of co-investors is 78. In subsequent rounds, the fund is usually supported by EcoR1 Capital, Visionnaire Ventures, Senvest Capital, out of 14 investors from our database.
We recorded the biggest number of exits for this fund in 2018. When Cormorant Asset Management invests, the average start-up valuation is 500 millions - 1 billion dollars. This fund was the most active in 2018. Additionally, in 2019 the fund was active. In real terms, this VC performs 2 percentage points less exits than other funds. The fund usually participates in 13-24 investment rounds per year. The most common rounds for this fund are in the range of 50 - 100 millions dollars. Cormorant Asset Management participates, on average, in 22 percentage points more than the average amount of lead investments in other funds.
Also, a start-up has to be aged 6-10 years to expect investment from this fund. The fund has no an exact preference in the amount of founders of companies in its portfolio. If there are 5+ founders in the start-up, the probability of getting the investment is low. Audentes Therapeutics, Innovent Biologics, ZAI Lab are amongst the various portfolio companies of this fund. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 3 other locations. Among the most popular investment industries for the fund are Medical, Life Science. However, the fund’s focus is not limited to this, since there are 14 more areas of investment.
We also identified another 2 core personnel in our database.
Group Appearance [how often fund is operating separately from groups with shared interest]
100.0% of cases
Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]
17.1% of cases
Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]
Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]
Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]
0.58 out of 1
Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]
Funds Investing in Previous
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.